observational
    2012

    A luteolin-containing dietary formulation in children with autism spectrum disorders: an open-label pilot study

    Theoharides TC, Asadi S, Panagiotidou S

    Published in Journal of Neuroinflammation

    Key Findings

    A luteolin-quercetin formulation was associated with improved communication and social interaction scores over 26 weeks in children with ASD.

    Conclusions

    Preliminary, uncontrolled signal only.

    Limitations

    Open label, no placebo group.

    Supplements Studied

    A luteolin-quercetin formulation was associated with improved communication scores in children with autism in an uncontrolled study.

    Quercetin
    Compound

    A luteolin-quercetin formulation was associated with improved communication and social interaction scores over 26 weeks in children with ASD.

    Study Details

    Year:2012
    Sample Size:37
    Duration:26 weeks
    Quality Score:3/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.